QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
4.625% Subordinated Notes due 2061 of Carlyle Finance L.L.C. |
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
Page | ||
Item 1. | ||
Unaudited Condensed Consolidated Financial Statements – March 31, 2024 and 2023: | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
March 31, 2024 | December 31, 2023 | ||
(Unaudited) | |||
Assets | |||
Cash and cash equivalents | $ | $ | |
Cash and cash equivalents held at Consolidated Funds | |||
Restricted cash | |||
Investments, including accrued performance allocations of $ March 31, 2024 and December 31, 2023, respectively | |||
Investments of Consolidated Funds | |||
Due from affiliates and other receivables, net | |||
Due from affiliates and other receivables of Consolidated Funds, net | |||
Fixed assets, net | |||
Lease right-of-use assets, net | |||
Deposits and other | |||
Intangible assets, net | |||
Deferred tax assets | |||
Total assets | $ | $ | |
Liabilities and equity | |||
Debt obligations | $ | $ | |
Loans payable of Consolidated Funds | |||
Accounts payable, accrued expenses and other liabilities | |||
Accrued compensation and benefits | |||
Due to affiliates | |||
Deferred revenue | |||
Deferred tax liabilities | |||
Other liabilities of Consolidated Funds | |||
Lease liabilities | |||
Accrued giveback obligations | |||
Total liabilities | |||
Commitments and contingencies | |||
Common stock, $ respectively) | |||
Additional paid-in-capital | |||
Retained earnings | |||
Accumulated other comprehensive loss | ( | ( | |
Non-controlling interests in consolidated entities | |||
Total equity | |||
Total liabilities and equity | $ | $ |
Three Months Ended March 31, | |||
2024 | 2023 | ||
Revenues | |||
Fund management fees | $ | $ | |
Incentive fees | |||
Investment income (loss) | |||
Performance allocations | ( | ||
Principal investment income | |||
Total investment income (loss) | ( | ||
Interest and other income | |||
Interest and other income of Consolidated Funds | |||
Total revenues | |||
Expenses | |||
Compensation and benefits | |||
Cash-based compensation and benefits | |||
Equity-based compensation | |||
Performance allocations and incentive fee related compensation | ( | ||
Total compensation and benefits | |||
General, administrative and other expenses | |||
Interest | |||
Interest and other expenses of Consolidated Funds | |||
Other non-operating expenses | |||
Total expenses | |||
Other income (loss) | |||
Net investment income (loss) of Consolidated Funds | ( | ||
Income before provision for income taxes | |||
Provision for income taxes | |||
Net income | |||
Net income attributable to non-controlling interests in consolidated entities | |||
Net income attributable to The Carlyle Group Inc. | $ | $ | |
Net income attributable to The Carlyle Group Inc. per common share (see Note 12) | |||
Basic | $ | $ | |
Diluted | $ | $ | |
Weighted-average common shares | |||
Basic | |||
Diluted |
Three Months Ended March 31, | |||
2024 | 2023 | ||
Net income | $ | $ | |
Other comprehensive income (loss) | |||
Foreign currency translation adjustments | ( | ||
Defined benefit plans | |||
Unrealized income for the period | |||
Reclassification adjustment for gain during the period, included in cash-based compensation and benefits expense | ( | ( | |
Other comprehensive income (loss) | ( | ||
Comprehensive income | |||
Comprehensive income attributable to non-controlling interests in consolidated entities | |||
Comprehensive income attributable to The Carlyle Group Inc. | $ | $ |
Common Shares | Common Stock | Additional Paid-in- Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Non- controlling Interests in Consolidated Entities | Total Equity | |||||||
Balance at December 31, 2023 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | — | — | ( | — | — | ( | ||||||
Net shares issued for equity-based awards | — | — | ( | — | — | ( | |||||||
Equity-based compensation | — | — | — | — | — | ||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income | — | — | — | — | |||||||||
Currency translation adjustments | — | — | — | — | ( | ( | ( | ||||||
Defined benefit plans, net | — | — | — | — | — | ||||||||
Balance at March 31, 2024 | $ | $ | $ | $( | $ | $ |
Common Shares | Common Stock | Additional Paid-in- Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Non- controlling Interests in Consolidated Entities | Total Equity | |||||||
Balance at December 31, 2022 | $ | $ | $ | $( | $ | $ | |||||||
Shares repurchased | ( | — | — | ( | — | — | ( | ||||||
Shares issued for equity-based awards | — | — | — | — | — | — | |||||||
Equity-based compensation | — | — | — | — | — | ||||||||
Dividend-equivalent rights on certain equity- based awards | — | — | ( | — | — | ||||||||
Contributions | — | — | — | — | — | ||||||||
Dividends and distributions | — | — | — | ( | — | ( | ( | ||||||
Net income | — | — | — | — | |||||||||
Currency translation adjustments | — | — | — | — | |||||||||
Defined benefit plans, net | — | — | — | — |